Back to the journal

Peptides

The only device named is a cleared syringe

The only device named is a cleared syringe

4 min read

Short answer. Condition 9 says the only drug-delivery device co-packaged with the compounded drug, or containing it, is an FDA 510(k)-cleared syringe [2]. The policy says more complex devices add risk [2]. As of Oct 29, 2026.

What that leaves out

The sentence is narrow on purpose. It names a syringe cleared through FDA's 510(k) pathway. It does not name an autoinjector pen, a pump, a nasal device, or a patch device as the thing packaged with the drug [2].

Clearance of a syringe is not approval of the peptide inside it. A 510(k) is a device decision. The peptide is still a compounded drug, and the notice says compounded drugs are not FDA-approved [1].

Routes and devices are different lines. Semax's named route is intranasal, and KPV's named routes are topical and oral [2]. Those routes do not convert a pen or a spray device into the syringe this condition names. If a device is packaged with the drug, the policy's limit is the cleared syringe [2].

What to look for

Ask what device, if any, comes with the product, and whether that syringe is FDA-cleared. A research-supply needle in a mailer is not described here. The compounder still has to be a state-licensed pharmacy, a federal facility, or a licensed physician [1].

This page does not teach injection technique. It does not give a dose. A clinician and the pharmacy label are the only place those instructions belong, if a prescription exists at all. Sommar Club does not prescribe or sell these six.

FAQ

Are all syringes allowed? The policy says an FDA 510(k)-cleared syringe [2].

Does a fancy pen make the product safer? The policy says the opposite concern: more complex devices introduce additional patient risk, which is why it limits the device [2].

Sources

  1. HHS notice, FR Doc. 2026-22192, filed Oct 28, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf

  2. HHS policy, condition 9 and Appendix B. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf

Education only. Not medical or legal advice. As of Oct 29, 2026.

Three minutes tonight.

Answer a few questions. Hear back from a clinician, usually within a day.

See if you qualifyFree online visit. Pay nothing unless approved.
Sommar Club NAD+ editorial product conceptNAD+
Sommar Club GLP-1 CARE editorial product conceptGLP-1 CARE
Sommar Club SERMORELIN editorial product conceptSERMORELIN